News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Chinese and Australian Patents Allowed for 22nd Century Group, Inc.’s NBB Nicotine Biosynthesis Gene



7/9/2012 10:08:54 AM

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group, Inc. (OTCBB: XXII), a company that has developed groundbreaking technology for tobacco harm reduction and smoking cessation products, today announced that the State Intellectual Property Office of the People's Republic of China issued a Notice of Allowance and IP Australia issued a patent to the company for the NBB gene, a gene responsible for nicotine production in the tobacco plant.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES